Can the external masculinization score predict the success of genetic testing in 46,XY DSD?
Genetic testing is judiciously applied to individuals with Disorders of Sex Development (DSD) and so it is necessary to identify those most likely to benefit from such testing. We hypothesized that the external masculinization score (EMS) is inversely associated with the likelihood of finding a path...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2015-05-01
|
Series: | AIMS Genetics |
Subjects: | |
Online Access: | http://www.aimspress.com/Genetics/article/206/fulltext.html |
id |
doaj-61d02e4231764e9fa8a500ad4fcea66d |
---|---|
record_format |
Article |
spelling |
doaj-61d02e4231764e9fa8a500ad4fcea66d2021-01-02T15:43:34ZengAIMS PressAIMS Genetics2377-11432015-05-012216317210.3934/genet.2015.2.16320150205Can the external masculinization score predict the success of genetic testing in 46,XY DSD?Ruthie Su0Margaret P. Adam1Linda Ramsdell2Patricia Y. Fechner3Margarett Shnorhavorian4Department of Urology, Division of Pediatric Urology, University of Wisconsin School of Medicine and Public Health, 1685 Highland Avenue, Madison, Wisconsin 53705, USADepartment of Pediatrics, Division of Genetic Medicine, University of Washington School of Medicine, 4800 Sandpoint Way NE, Seattle, WA 98105, USADepartment of Pediatrics, Division of Genetic Medicine, University of Washington School of Medicine, 4800 Sandpoint Way NE, Seattle, WA 98105, USADepartment of Pediatrics, Division of Endocrinology, University of Washington School of Medicine, 4800 Sandpoint Way NE, Seattle, WA 98105, USADepartment of Urology, Division of Pediatric Urology, University of Washington School of Medicine, 4800 Sandpoint Way NE, Seattle, WA 98105, USGenetic testing is judiciously applied to individuals with Disorders of Sex Development (DSD) and so it is necessary to identify those most likely to benefit from such testing. We hypothesized that the external masculinization score (EMS) is inversely associated with the likelihood of finding a pathogenic genetic variant. Patients with 46,XY DSD from a single institution evaluated from 1994-2014 were included. Results of advanced cytogenetic and gene sequencing tests were recorded. An EMS score (range 0-12) was assigned to each patient according to the team's initial external genitalia physical examination. During 1994-2011, 44 (40%) patients with 46,XY DSD were evaluated and underwent genetic testing beyond initial karyotype; 23% (10/44) had a genetic diagnosis made by gene sequencing or array. The median EMS score of those with an identified pathogenic variant was significantly different from those in whom no confirmed genetic cause was identified [median 3 (95% CI, 2-6) versus 6 (95% CI, 5-7), respectively (<em>p</em> = 0.02)], but limited to diagnoses of complete or partial androgen insensitivity (8/10) or 5-reductase deficiency (2/10). In the modern cohort (2012-2014), the difference in median EMS in whom a genetic cause was or was not identified approached significance (<em>p</em> = 0.05, median 3 (95% CI, 0-7) versus 7 (95% CI, 6-9), respectively). When all patients from 1994-2014 are pooled, the EMS is significantly different amongst those with compared to those without a genetic cause (median EMS 3 vs. 6, <em>p</em> < 0.02). We conclude that an EMS of 3 or less may indicate a higher likelihood of identifying a genetic cause of 46,XY DSD and justify genetic screening, especially when androgen insensitivity is suspected.http://www.aimspress.com/Genetics/article/206/fulltext.htmldisorders of sex development (DSD)external masculinization score (EMS)genetic testingcytogenetics46,XY |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ruthie Su Margaret P. Adam Linda Ramsdell Patricia Y. Fechner Margarett Shnorhavorian |
spellingShingle |
Ruthie Su Margaret P. Adam Linda Ramsdell Patricia Y. Fechner Margarett Shnorhavorian Can the external masculinization score predict the success of genetic testing in 46,XY DSD? AIMS Genetics disorders of sex development (DSD) external masculinization score (EMS) genetic testing cytogenetics 46,XY |
author_facet |
Ruthie Su Margaret P. Adam Linda Ramsdell Patricia Y. Fechner Margarett Shnorhavorian |
author_sort |
Ruthie Su |
title |
Can the external masculinization score predict the success of genetic testing in 46,XY DSD? |
title_short |
Can the external masculinization score predict the success of genetic testing in 46,XY DSD? |
title_full |
Can the external masculinization score predict the success of genetic testing in 46,XY DSD? |
title_fullStr |
Can the external masculinization score predict the success of genetic testing in 46,XY DSD? |
title_full_unstemmed |
Can the external masculinization score predict the success of genetic testing in 46,XY DSD? |
title_sort |
can the external masculinization score predict the success of genetic testing in 46,xy dsd? |
publisher |
AIMS Press |
series |
AIMS Genetics |
issn |
2377-1143 |
publishDate |
2015-05-01 |
description |
Genetic testing is judiciously applied to individuals with Disorders of Sex Development (DSD) and so it is necessary to identify those most likely to benefit from such testing. We hypothesized that the external masculinization score (EMS) is inversely associated with the likelihood of finding a pathogenic genetic variant. Patients with 46,XY DSD from a single institution evaluated from 1994-2014 were included. Results of advanced cytogenetic and gene sequencing tests were recorded. An EMS score (range 0-12) was assigned to each patient according to the team's initial external genitalia physical examination. During 1994-2011, 44 (40%) patients with 46,XY DSD were evaluated and underwent genetic testing beyond initial karyotype; 23% (10/44) had a genetic diagnosis made by gene sequencing or array. The median EMS score of those with an identified pathogenic variant was significantly different from those in whom no confirmed genetic cause was identified [median 3 (95% CI, 2-6) versus 6 (95% CI, 5-7), respectively (<em>p</em> = 0.02)], but limited to diagnoses of complete or partial androgen insensitivity (8/10) or 5-reductase deficiency (2/10). In the modern cohort (2012-2014), the difference in median EMS in whom a genetic cause was or was not identified approached significance (<em>p</em> = 0.05, median 3 (95% CI, 0-7) versus 7 (95% CI, 6-9), respectively). When all patients from 1994-2014 are pooled, the EMS is significantly different amongst those with compared to those without a genetic cause (median EMS 3 vs. 6, <em>p</em> < 0.02). We conclude that an EMS of 3 or less may indicate a higher likelihood of identifying a genetic cause of 46,XY DSD and justify genetic screening, especially when androgen insensitivity is suspected. |
topic |
disorders of sex development (DSD) external masculinization score (EMS) genetic testing cytogenetics 46,XY |
url |
http://www.aimspress.com/Genetics/article/206/fulltext.html |
work_keys_str_mv |
AT ruthiesu cantheexternalmasculinizationscorepredictthesuccessofgenetictestingin46xydsd AT margaretpadam cantheexternalmasculinizationscorepredictthesuccessofgenetictestingin46xydsd AT lindaramsdell cantheexternalmasculinizationscorepredictthesuccessofgenetictestingin46xydsd AT patriciayfechner cantheexternalmasculinizationscorepredictthesuccessofgenetictestingin46xydsd AT margarettshnorhavorian cantheexternalmasculinizationscorepredictthesuccessofgenetictestingin46xydsd |
_version_ |
1724352610075410432 |